{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T09:25:05Z","timestamp":1787390705389,"version":"build-2736575974"},"reference-count":58,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012217","name":"Xuzhou Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012217","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.cjca.2026.01.020","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:14:01Z","timestamp":1769040841000},"page":"1538-1550","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prognostic Value of Angiography-Derived Microcirculatory Resistance and Vericiguat Therapy in Dilated Cardiomyopathy With Reduced Ejection Fraction"],"prefix":"10.1016","volume":"42","author":[{"given":"Chaofan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengxin","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengcheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiancun","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haochen","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongye","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongda","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2026.01.020_bib1","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart disease and stroke statistics\u20142020 update: a report from the American Heart Association","volume":"141","author":"Virani","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2026.01.020_bib2","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1001\/jama.2020.10262","article-title":"Heart failure with reduced ejection fraction: a review","volume":"324","author":"Murphy","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2026.01.020_bib3","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.21037\/qims-22-1060","article-title":"The role of the angiography-derived index of microcirculatory resistance in the prognosis of patients with dilated cardiomyopathy","volume":"13","author":"Li","year":"2023","journal-title":"Quant Imaging Med Surg"},{"key":"10.1016\/j.cjca.2026.01.020_bib4","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/eurheartj\/ehv727","article-title":"Proposal for a revised definition of dilated cardiomyopathy, hypokinetic nondilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases","volume":"37","author":"Pinto","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2026.01.020_bib5","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/eurheartj\/ehi795","article-title":"The prognostic impact of coronary flow-reserve assessed by Doppler echocardiography in nonischaemic dilated cardiomyopathy","volume":"27","author":"Rigo","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2026.01.020_bib6","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1161\/hc0202.102119","article-title":"Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction","volume":"105","author":"Neglia","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2026.01.020_bib7","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/j.jcmg.2018.10.032","article-title":"Microvascular dysfunction in dilated cardiomyopathy: a quantitative stress perfusion cardiovascular magnetic resonance study","volume":"12","author":"Gulati","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.cjca.2026.01.020_bib8","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/164_2016_100","article-title":"Novel sGC stimulators and sGC activators for the treatment of heart failure","volume":"243","author":"Breitenstein","year":"2017","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.cjca.2026.01.020_bib9","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1111\/cts.13677","article-title":"Vericiguat, a novel sGC stimulator: mechanism of action, clinical, and translational science","volume":"16","author":"Trujillo","year":"2023","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.cjca.2026.01.020_bib10","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/ejhf.135","article-title":"Rationale and design of the Soluble Guanylate Cyclase Stimulator in Heart Failure Studies (SOCRATES)","volume":"16","author":"Pieske","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2026.01.020_bib11","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1001\/jama.2015.15734","article-title":"Effect of vericiguat, a soluble guanylate cyclase stimulator, on natriuretic peptide levels in patients with worsening chronic heart failure and reduced ejection fraction: the SOCRATES-REDUCED randomized trial","volume":"314","author":"Gheorghiade","year":"2015","journal-title":"Jama"},{"key":"10.1016\/j.cjca.2026.01.020_bib12","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1016\/j.jacc.2018.09.042","article-title":"Coronary microvascular disease pathogenic mechanisms and therapeutic options: JACC state-of-the-art review","volume":"72","author":"Taqueti","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2026.01.020_bib13","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1161\/CIRCULATIONAHA.114.009716","article-title":"Interaction of impaired coronary flow reserve and cardiomyocyte injury on adverse cardiovascular outcomes in patients without overt coronary artery disease","volume":"131","author":"Taqueti","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2026.01.020_bib14","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12872-021-01887-w","article-title":"Index of microcirculatory resistance predicts long term cardiac systolic function in patients with STEMI undergoing primary PCI","volume":"21","author":"Qi","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.cjca.2026.01.020_bib15","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.123.013185","article-title":"Integrated assessment of computational coronary physiology from a single angiographic view in patients undergoing TAVI","volume":"16","author":"Fezzi","year":"2023","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2026.01.020_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2025.133322","article-title":"Prognostic value of angiography-derived microcirculatory resistance in patients undergoing rotational atherectomy\u2014a multi-center study","volume":"434","author":"Zhang","year":"2025","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2026.01.020_bib17","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC guidelines for the management of cardiomyopathies","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2026.01.020_bib18","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2026.01.020_bib19","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1253\/circj.CJ-16-0944","article-title":"Value of 3-dimensional speckle tracking echocardiography in the prediction of microvascular obstruction and left ventricular remodeling in patients with ST-elevation myocardial infarction","volume":"81","author":"Sugano","year":"2017","journal-title":"Circ J"},{"key":"10.1016\/j.cjca.2026.01.020_bib20","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.3390\/jpm12111798","article-title":"In vivo validation of a novel computational approach to assess microcirculatory resistance based on a single angiographic view","volume":"12","author":"Fan","year":"2022","journal-title":"J Pers Med"},{"key":"10.1016\/j.cjca.2026.01.020_bib21","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.jcin.2014.12.232","article-title":"Fractional flow reserve and coronary bifurcation anatomy: a novel quantitative model to assess and report the stenosis severity of bifurcation lesions","volume":"8","author":"Tu","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2026.01.020_bib22","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.034996","article-title":"Social risk profile and cardiovascular-kidney-metabolic syndrome in US adults","volume":"13","author":"Li","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cjca.2026.01.020_bib23","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jacc.2025.05.040","article-title":"Guideline-directed medical therapy and outcomes among patients with heart failure with improved ejection fraction","volume":"86","author":"Min","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2026.01.020_bib24","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1038\/s41591-022-02102-9","article-title":"Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial","volume":"28","author":"Vardeny","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.cjca.2026.01.020_bib25","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.1093\/eurheartj\/ehab670","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2026.01.020_bib26","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1161\/CIRCRESAHA.117.311812","article-title":"Cardiomyopathies: an overview","volume":"121","author":"Braunwald","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2026.01.020_bib27","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00380-017-1069-1","article-title":"Late gadolinium enhancement on cardiac magnetic resonance imaging is associated with coronary endothelial dysfunction in patients with dilated cardiomyopathy","volume":"33","author":"Nakayama","year":"2018","journal-title":"Heart Vessels"},{"key":"10.1016\/j.cjca.2026.01.020_bib28","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/j.jcin.2016.07.013","article-title":"Diagnostic accuracy of fast computational approaches to derive fractional flow reserve from diagnostic coronary angiography: the international multicenter FAVOR pilot study","volume":"9","author":"Tu","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2026.01.020_bib29","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1016\/j.jacc.2017.10.035","article-title":"Diagnostic accuracy of angiography-based quantitative flow ratio measurements for online assessment of coronary stenosis","volume":"70","author":"Xu","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2026.01.020_bib30","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.124.017506","article-title":"Angiography-derived microcirculatory resistance in detecting microvascular obstruction and predicting heart failure after STEMI","volume":"18","author":"Lu","year":"2025","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.cjca.2026.01.020_bib31","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000037022","article-title":"Diagnostic value of angiography-derived index of microcirculatory resistance (AMR) for coronary microcirculatory dysfunction (CMD) and its prognostic significance in patients with chronic coronary syndromes in the smoking population","volume":"103","author":"Qiu","year":"2024","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cjca.2026.01.020_bib32","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.jcmg.2018.02.018","article-title":"Index of microcirculatory resistance as a tool to characterize microvascular obstruction and to predict infarct size regression in patients with STEMI undergoing primary PCI","volume":"12","author":"De Maria","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.cjca.2026.01.020_bib33","first-page":"1063","article-title":"Prognostic value of the index of microcirculatory resistance after percutaneous coronary intervention in patients with non\u2013ST-segment elevation acute coronary syndrome","volume":"92","author":"Murai","year":"2018","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2026.01.020_bib34","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.repc.2021.07.013","article-title":"Index of microcirculatory resistance in the assessment of coronary microvascular dysfunction in hypertrophic cardiomyopathy","volume":"41","author":"Aguiar Rosa","year":"2022","journal-title":"Rev Port Cardiol"},{"key":"10.1016\/j.cjca.2026.01.020_bib35","first-page":"687","article-title":"Increased index of microcirculatory resistance in older patients with heart failure with preserved ejection fraction","volume":"15","author":"Xu","year":"2018","journal-title":"J Geriatr Cardiol"},{"key":"10.1016\/j.cjca.2026.01.020_bib36","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1007\/s10554-021-02254-8","article-title":"Angiography-derived index of microcirculatory resistance (IMRangio) as a novel pressure-wire\u2013free tool to assess coronary microvascular dysfunction in acute coronary syndromes and stable coronary artery disease","volume":"37","author":"Scarsini","year":"2021","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.cjca.2026.01.020_bib37","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s10554-020-01831-7","article-title":"Angiography-derived index of microcirculatory resistance as a novel, pressure-wire-free tool to assess coronary microcirculation in ST elevation myocardial infarction","volume":"36","author":"De Maria","year":"2020","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.cjca.2026.01.020_bib38","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4244\/AIJ-D-22-00022","article-title":"Coronary physiology in the catheterisation laboratory: an A to Z practical guide","volume":"8","author":"Fezzi","year":"2022","journal-title":"AsiaIntervention"},{"key":"10.1016\/j.cjca.2026.01.020_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/clc.24196","article-title":"Application of AMR in evaluating microvascular dysfunction after ST-elevation myocardial infarction","volume":"47","author":"Wang","year":"2024","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.cjca.2026.01.020_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2025.133220","article-title":"Angiography-derived index of microcirculatory resistance as a novel tool to assess coronary microvascular dysfunction in patients with diabetic cardiomyopathy","volume":"431","author":"Gao","year":"2025","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2026.01.020_bib41","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ejim.2021.05.027","article-title":"Prognostic impact of coronary microvascular dysfunction in patients with myocardial infarction with nonobstructive coronary arteries","volume":"92","author":"Abdu","year":"2021","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.cjca.2026.01.020_bib42","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0140-6736(23)01241-2","article-title":"Dilated cardiomyopathy: causes, mechanisms, and current and future treatment approaches","volume":"402","author":"Heymans","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2026.01.020_bib43","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.038644","article-title":"Heart disease mortality in the United States 1970 to 2022","volume":"14","author":"King","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cjca.2026.01.020_bib44","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.atherosclerosis.2020.12.008","article-title":"Coronary provocative tests in the catheterization laboratory: pathophysiological bases, methodological considerations and clinical implications","volume":"318","author":"Montone","year":"2021","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cjca.2026.01.020_bib45","doi-asserted-by":"crossref","first-page":"6560","DOI":"10.3390\/jcm11216560","article-title":"Microvascular dysfunction in hypertrophic cardiomyopathy","volume":"11","author":"Pelliccia","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.cjca.2026.01.020_bib46","article-title":"Prognostic value of coronary angiography-derived index of microvascular resistance in patients with hypertrophic cardiomyopathy","volume":"6","author":"Zhang","year":"2025","journal-title":"MedComm (2020)"},{"key":"10.1016\/j.cjca.2026.01.020_bib47","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ijcard.2022.07.046","article-title":"Myocardial infarction with nonobstructive coronary arteries in hypertrophic cardiomyopathy vs Fabry disease","volume":"369","author":"Graziani","year":"2022","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2026.01.020_bib48","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/j.jacc.2004.08.051","article-title":"Regional coronary flow and contractile reserve in patients with idiopathic dilated cardiomyopathy","volume":"44","author":"Skalidis","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2026.01.020_bib49","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12933-022-01607-4","article-title":"Dapagliflozin improves myocardial flow reserve in patients with type 2 diabetes: the DAPAHEART trial: a preliminary report","volume":"21","author":"Leccisotti","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.cjca.2026.01.020_bib50","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.020418","article-title":"Effects of empagliflozin on myocardial flow reserve in patients with type 2 diabetes mellitus: the SIMPLE trial","volume":"10","author":"J\u00fcrgens","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cjca.2026.01.020_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.110141","article-title":"Sodium-Glucose Co-transporter Inhibition in Patients With Newly Detected Glucose Abnormalities and a Recent Myocardial Infarction (SOCOGAMI)","volume":"193","author":"Lundin","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.cjca.2026.01.020_bib52","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/hrt.2006.091751","article-title":"Nebivolol improves coronary flow reserve in patients with idiopathic dilated cardiomyopathy","volume":"93","author":"Erdogan","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.cjca.2026.01.020_bib53","first-page":"217","article-title":"[The effect of carvedilol on coronary flow reserve in patients with dilated cardiomyopathy]","volume":"49","author":"Fan","year":"2010","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"10.1016\/j.cjca.2026.01.020_bib54","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jchf.2017.08.013","article-title":"A multicenter, randomized, double-blind, placebo-controlled trial of the efficacy and safety of the oral soluble guanylate cyclase stimulator: the VICTORIA trial","volume":"6","author":"Armstrong","year":"2018","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cjca.2026.01.020_bib55","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1093\/eurheartj\/ehaa857","article-title":"Assessment and pathophysiology of microvascular disease: recent progress and clinical implications","volume":"42","author":"Masi","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2026.01.020_bib56","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/apha.12646","article-title":"Endothelial dysfunction and vascular disease\u2014a 30th anniversary update","volume":"219","author":"Vanhoutte","year":"2017","journal-title":"Acta Physiol (Oxf)"},{"key":"10.1016\/j.cjca.2026.01.020_bib57","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/CIRCRESAHA.124.326029","article-title":"GUCY1A1-LDHA axis suppresses ferroptosis in cardiac ischemia-reperfusion injury","volume":"137","author":"Yin","year":"2025","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2026.01.020_bib58","doi-asserted-by":"crossref","DOI":"10.1111\/anec.13115","article-title":"Vericiguat improves cardiac function and microcirculation of a male patient with Fabry disease: a case report","volume":"29","author":"Zhou","year":"2024","journal-title":"Ann Noninvasive Electrocardiol"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X26000486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X26000486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T08:45:47Z","timestamp":1787388347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X26000486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":58,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0828282X26000486"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2026.01.020","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic Value of Angiography-Derived Microcirculatory Resistance and Vericiguat Therapy in Dilated Cardiomyopathy With Reduced Ejection Fraction","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2026.01.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the Canadian Cardiovascular Society.","name":"copyright","label":"Copyright"}]}}